These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 38402500

  • 21. Clinical significance of M-type phospholipase A2 receptor and thrombospondin Type 1 domain-containing 7A in primary membranous nephropathy.
    Gong Z, Yuan S, Zhu X, Wang Y, Yu F, Yang D, Xu X, Liu H, Li J, Sun L.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun 28; 45(6):693-700. PubMed ID: 32879127
    [Abstract] [Full Text] [Related]

  • 22. Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists.
    Wada T, Shimizu S, Koizumi M, Sofue T, Nishiwaki H, Sasaki S, Nakaya I, Oe Y, Ishimoto T, Furuichi K, Okada H, Kurita N.
    Clin Exp Nephrol; 2023 Sep 28; 27(9):767-775. PubMed ID: 37310570
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
    Radice A, Pieruzzi F, Trezzi B, Ghiggeri G, Napodano P, D'Amico M, Stellato T, Brugnano R, Ravera F, Rolla D, Pesce G, Giovenzana ME, Londrino F, Cantaluppi V, Pregnolato F, Volpi A, Rombolà G, Moroni G, Ortisi G, Sinico RA.
    J Nephrol; 2018 Apr 28; 31(2):271-278. PubMed ID: 29081027
    [Abstract] [Full Text] [Related]

  • 24. Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.
    Tampoia M, Migliucci F, Villani C, Abbracciavento L, Rossini M, Fumarulo R, Gesualdo L, Montinaro V.
    J Nephrol; 2018 Dec 28; 31(6):899-905. PubMed ID: 30187382
    [Abstract] [Full Text] [Related]

  • 25. Antibodies against M-Type Phospholipase A2 Receptor May Predict Treatment Response and Outcome in Membranous Nephropathy.
    Qu Z, Zhang MF, Cui Z, Wang J, Wang M, Zhang YM, Wang F, Wang X, Meng LQ, Cheng XY, Liu G, Zhao MH.
    Am J Nephrol; 2018 Dec 28; 48(6):438-446. PubMed ID: 30472708
    [Abstract] [Full Text] [Related]

  • 26. PLA2R and membranous nephropathy: A 3 year prospective Australian study.
    Hill PA, McRae JL, Dwyer KM.
    Nephrology (Carlton); 2016 May 28; 21(5):397-403. PubMed ID: 26369693
    [Abstract] [Full Text] [Related]

  • 27. [The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy].
    Lin W, Li H, Li X, Qin Y, Su Y, Yu Y, Guan Y, Duan L, Li Y, Wen Y, Li X.
    Zhonghua Nei Ke Za Zhi; 2015 Sep 28; 54(9):783-8. PubMed ID: 26674797
    [Abstract] [Full Text] [Related]

  • 28. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.
    Yin P, Wang J, Liang W, Zhan L, Liu Y, Lin J, Chen X, He Y, Jian H, Xie Z, Tan X, Ye Q, Huang F.
    Ren Fail; 2020 Nov 28; 42(1):675-683. PubMed ID: 32674643
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA.
    Kidney Int; 2012 Oct 28; 82(7):797-804. PubMed ID: 22673885
    [Abstract] [Full Text] [Related]

  • 32. PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis.
    Dhaouadi T, Abdellatif J, Trabelsi R, Gaied H, Chamkhi S, Sfar I, Goucha R, Ben Hamida F, Ben Abdallah T, Gorgi Y.
    PLoS One; 2020 Oct 28; 15(10):e0240025. PubMed ID: 33002091
    [Abstract] [Full Text] [Related]

  • 33. [Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy].
    Wu X, Wen S, Zhu X, Yuan S, Xu X, Yang D, Sun L, Liu H, Liu F.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Apr 28; 42(4):395-399. PubMed ID: 28490696
    [Abstract] [Full Text] [Related]

  • 34. [Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R].
    Kozioł M, Sikora A, Kozioł-Montewka M, Smarz-Widelska I, Orłowska-Kowalik G, Pyszna W, Załuska W, Ksiazek A.
    Pol Merkur Lekarski; 2014 Mar 28; 36(213):171-4. PubMed ID: 24779214
    [Abstract] [Full Text] [Related]

  • 35. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
    Tian C, Li L, Liu T, Qu X, Qiu Y.
    Int Urol Nephrol; 2019 Aug 28; 51(8):1371-1377. PubMed ID: 31227982
    [Abstract] [Full Text] [Related]

  • 36. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.
    Liu L, Chang B, Wu X, Guo Y, Pan Y, Yang L.
    Vasc Health Risk Manag; 2018 Aug 28; 14():103-108. PubMed ID: 29881283
    [Abstract] [Full Text] [Related]

  • 37. Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods.
    Katsumata Y, Okamoto Y, Moriyama T, Moriyama R, Kawamoto M, Hanaoka M, Uchida K, Nitta K, Harigai M.
    Immunol Med; 2020 Mar 28; 43(1):47-56. PubMed ID: 31910103
    [Abstract] [Full Text] [Related]

  • 38. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?].
    Netti GS, Ranieri E.
    G Ital Nefrol; 2014 Mar 28; 31(3):. PubMed ID: 25030016
    [Abstract] [Full Text] [Related]

  • 39. Membranous nephropathy: integrating basic science into improved clinical management.
    Cattran DC, Brenchley PE.
    Kidney Int; 2017 Mar 28; 91(3):566-574. PubMed ID: 28065518
    [Abstract] [Full Text] [Related]

  • 40. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.
    Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA.
    J Am Soc Nephrol; 2014 Jun 28; 25(6):1357-66. PubMed ID: 24610926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.